ACTA1 and heart failure: We found that 5 mg/kg body weight of ISO treatment for 5 days was sufficient to increase the HW/BW ratio and expression of hypertrophy biomarker Acta1, but did not increase heart failure biomarkers, such as Anp and Bnp (Fig. 2C–F).